Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells

Overview of attention for article published in Breast Cancer Research, August 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 47 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Relaxin fusion polypeptides and uses thereof

Grant US-9382305-B2

United States of America

FUSION PROTEINS RELEASING RELAXIN AND USES THEREOF

Application WO-2013007563-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.